CDT Equity Inc. Common Stock
CDTConduit Pharmaceuticals Inc. (CDT) is a biopharmaceutical company focused on developing innovative therapies for the treatment of inflammatory and autoimmune diseases. The company emphasizes research and development to create targeted medications aimed at improving patient outcomes in conditions such as rheumatoid arthritis and other chronic inflammatory disorders.
Company News
Conduit Pharmaceuticals has restructured a $2.65 million loan note with Nirland Limited, removing restrictive clauses and making the note convertible. The company has also secured $1.2 million in new promissory notes, positioning it to access its At-The-Market (ATM) facility to support its note repayment obligations, operations, and clinical obje...
Bloom Energy shares jumped 12.1% after announcing a strategic partnership with CoreWeave to deploy its fuel cells for on-site power generation at a data center. Several other stocks also saw significant pre-market movements, both positive and negative.
Conduit Pharmaceuticals shares traded higher by over 50% after the company announced it received patent approval for its lead asset targeting autoimmune diseases, which allows it to participate in the Patent Prosecution Highway and enhances the likelihood of approvals in major jurisdictions.
Match Group shares jumped 8% in pre-market trading after Starboard Value took a stake of over 6.5% in the company and is advocating for a potential sale. Several other stocks also saw significant pre-market movement.
SAN DIEGO and LONDON, March 11, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ("Conduit Pharmaceuticals" or "Conduit") today announced the opening of cutting-edge laboratory space in Cambridge, United Kingdom, a global centre for research and development for companies at the forefront of life science innovation. This strat...